33 /100
MEDIUM RISK
Score updated May 30, 2026

NTLA — Intellia Therapeutics, Inc. Dilution Risk Tracker

Track NTLA dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track NTLA — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
25
📊 Float Risk
17
⚠️ Warrant Exposure
15
🔄Convertible Debt—

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
9%
💰 Capital Raise 18%
• Active ATM program with $180M remaining capacity
🔔 Track NTLA — Get forecast alerts →

💹 Market Data

Market Cap$1.97B
Shares Outstanding139.72M
Float134.16M
Cash$375.99M
Debt$80.49M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 0.0% shares (2025Q4 vs prior)
296 institutional holders · 111.28M shares
#1 ARK Investment Management LLC 14.21M shares
#2 VANGUARD GROUP INC 13.01M shares
#3 BlackRock, Inc. 10.28M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest51.85M
Days to Cover7.7
% of Float38.6%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

8-K 8K EVENT Apr 30, 2026
424B5 ATM Apr 29, 2026
424B5 ATM Apr 27, 2026
4 INSIDER TRANSACTION Mar 03, 2026
4 INSIDER TRANSACTION Mar 03, 2026
Full SEC filing analysis available with free account →

📰 Recent News

No recent news
Track NTLA Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking NTLA — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
Similar risk profiles: ADAG AIEV AIP ALLO ALOY
🔬 More Research for NTLA
📊 NTLA FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 NTLA Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.